On June 24, HRSA announced that it had issued new grant award terms to its HRSA-funded health centers to provide insulin and injectable epinephrine at or below the 340B price paid by the health center for the drugs. HRSA...more
6/27/2025
/ Drug Pricing ,
Executive Orders ,
Federal Funding ,
Government Agencies ,
Grants ,
Healthcare Facilities ,
Healthcare Reform ,
HRSA ,
Prescription Drugs ,
Regulatory Requirements ,
Reporting Requirements ,
Section 340B ,
Trump Administration